Its expression appears to be influenced by the liver’s metabolic state in MetS patients, reinforcing the hypothesis that GPHB5 may play a critical role in the pathophysiology of metabolic syndrome [73]. The gene discussed is GPHB5; the disease is metabolic syndrome.